[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Fusco R., Cordaro M., Genovese T., Impellizzeri D., Siracusa R., Gugliandolo E., Peritore A.F., DAmico R., Crupi R., Cuzzocrea S., et al
Conversely, reduction of lysosomal cholesterol using 25-hydroxycholesterol, an oxysterol, which acts as a ligand for liver X receptors and suppresses sterol synthesis, decreases cholesterol accumulation and protected ASMase knockout mice against APAP-induced injury
rufipes and systematically subjected to bioinformatic analysis and recombination identification
Furthermore, we demonstrated that RSL3 treatment impairs the phosphorylation of other downstream mTOR-related proteins, such as S6 and 4E-BP-1
PMID: 9685390 Rebouche CJ
Another scenario is a patient who has been using a GLP-1 therapy for a few years, has reached a weight-loss plateau, and is now in the maintenance phase of treatment